CRO for Clinical Trials in Respiratory Diseases
Respiratory diseases are leading causes of death and disability worldwide. About 65 million people suffer from chronic obstructive pulmonary disease (COPD) and 3 million die from it annually, making it the third leading cause of death worldwide. About 334 million people suffer from asthma, the most common chronic disease of childhood affecting 14% of all children globally. Pneumonia kills millions of people annually and is a leading cause of death among children under 5 years old.
Sofpromed is a clinical research organization (CRO) specialized in the management of phase I-IV clinical trials in respiratory diseases. We manage trials in the United States, Europe, United Kingdom, and globally.
Among others, we are able to manage clinical trials in the following respiratory diseases:
- Chronic obstructive pulmonary disease (COPD)
- Emphysema
- Asthma
- Pneumonia
- Pleural effusion
- Chronic bronchitis
- Pulmonary fibrosis
Our CRO services include:
- Regulatory
- Clinical operations
- Site selection and activation
- Site management
- Monitoring
- Data management
- Biostatistics
- Statistical programming
- Medical writing
- Clinical trial logistics
Please do not hesitate to contact us to obtain additional information about our CRO services for clinical trials in infectious diseases.